RTN4R and neoplasm: Interestingly, compounds coupled to peptides containing the NGR sequence, a CD13 recognition motif, can bind CD13-positive tumor blood vessels, but not other CD13-rich normal tissues [2, 20], suggesting that different forms of this enzyme are expressed in tumors and normal tissues.